Akero Therapeutics
AKRO
#3360
Rank
C$4.48 B
Marketcap
$56.34
Share price
-4.67%
Change (1 day)
79.72%
Change (1 year)

Akero Therapeutics (AKRO) - Cash on Hand

Cash on Hand as of December 2024 : C$1.04 Billion

According to Akero Therapeutics's latest financial reports the company has C$1.04 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Akero Therapeutics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$1.06 B46.17%
2023-12-31C$0.72 B52.97%
2022-12-31C$0.47 B98.77%
2021-12-31C$0.23 B-29.89%
2020-12-31C$0.34 B92.1%
2019-12-31C$0.17 B72.13%
2018-12-31C$0.10 B13665.4%
2017-12-31C$0.75 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.36 B-65.55%๐Ÿ‡บ๐Ÿ‡ธ USA